Editors, Publishers, Impact Factors, and Reprint Income

1. LundhA

BarbateskovicM

HróbjartssonA

GøtzschePC

2010 Conflicts of interest at medical journals: The influence of industry-supported randomised trials on the journal impact factor. PLoS Med 7 e354 doi:10.1371/journal.pmed.1000354

2. ConenD

TorresJ

RidkerPM

2008 Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005. Circulation 118 1321 1327

3. KulkarniAV

BusseJW

ShamsI

2007 Characteristics associated with citation rate of the medical literature. PLoS ONE 2 e403 doi:10.1371/journal.pone.0000403

4. BhaudariM

BusseJ

DevereauxPJ

MontoriVM

SwiatkowskiM

2007 Factors associated with citation rates in the orthopaedic literature. Can J Surg 50 119 123

5. PhillipsDP

KanterEJ

BednarczykB

TastadPL

1991 Importance of the lay press in the transmission of medical knowledge to the scientific community. N Eng J Med 325 1180 1183

6. ChapmanS

NguyenTN

WhiteC

2006 Press-released papers are more downloaded and cited. Tob Control 16 71

7. RossJ

HillKP

EgilmanDS

KrumholzH

2008 Guest authorship and ghost writing in publications related to Rofecoxib: a case study of industry documents from Rofecoxib litigation. JAMA 299 1800 1812

8. LexchinJ

BeroLA

DjulbegovicB

ClarkO

2003 Pharmaceutical industry sponsorship and research outcome and quality: a systematic review. BMJ 326 1167 1170

9. FontanarosaPB

FlanaginA

DeAngelisCD

2005 Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA 294 110 111

10. RothmanDJ

McDonaldWJ

BerkowitzCD

ChimonasSC

DeAngelisCD

2009 Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA 301 1367 1372

11. Scott-Lichter D and the editorial policy committee, Council of Science Editors CSE's white paper on promoting integrity in scientific journal publications, 2009 update, Reston, Va: 2009. Available: http://www.councilscienceeditors.org/i4a/pages/index.cfm?pageid=3354#2.1.3. Accessed 24 September 2010

12. AngellM

January 15, 2009 Drug companies and doctors: A story of corruption. The New York Review of Books 56. Available: http://www.nybooks.com/articles/archives/2009/jan/15/drug-companies-doctorsa-story-of-corruption/. Accessed 20 September 2010